Susan Whaley - Procter Gamble Chief Sec
PG Stock | ARS 13,175 125.00 0.96% |
Insider
Susan Whaley is Chief Sec of Procter Gamble DRC
Age | 49 |
Phone | 513 983 1100 |
Web | https://www.pginvestor.com |
Susan Whaley Latest Insider Activity
Tracking and analyzing the buying and selling activities of Susan Whaley against Procter Gamble stock is an integral part of due diligence when investing in Procter Gamble. Susan Whaley insider activity provides valuable insight into whether Procter Gamble is net buyers or sellers over its current business cycle. Note, Procter Gamble insiders must abide by specific rules, including filing SEC forms every time they buy or sell Procter Gamble'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Susan Whaley over a year ago Procter Gamble exotic insider transaction detected | ||
Susan Whaley over a year ago Acquisition by Susan Whaley of 20952 shares of Procter Gamble subject to Rule 16b-3 |
Procter Gamble Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3202 %, meaning that it generated $0.3202 on every $100 dollars invested by stockholders. Procter Gamble's management efficiency ratios could be used to measure how well Procter Gamble manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Pablo Bassi | Ternium SA DRC | 60 | |
Sebastin Mart | Ternium SA DRC | N/A | |
Ravikumar Radhakrishnan | American Express Co | 51 | |
Osvaldo Pollice | Central Puerto SA | N/A | |
Enrique Terraneo | Central Puerto SA | 49 | |
Manpreet Grewal | United States Steel | 44 | |
Rubn Herrera | Ternium SA DRC | 65 | |
Martn Barbiero | Central Puerto SA | 52 | |
David Denton | Pfizer Inc | 58 | |
David Nigro | American Express Co | 61 | |
Christopher CFA | Pfizer Inc | N/A | |
Ivana Rossi | Edesa Holding SA | N/A | |
Justo Senz | Central Puerto SA | 65 | |
Meghan Cox | United States Steel | N/A | |
Hugo Cabral | Capex SA | N/A | |
Vivian Zhou | American Express Co | N/A | |
Claudia Biasotti | Capex SA | N/A | |
Mikael MD | Pfizer Inc | 65 | |
Jorge LLera | Capex SA | N/A | |
Roberto Demidchuk | Ternium SA DRC | 61 | |
Jessica Quinn | American Express Co | 50 |
Management Performance
Return On Equity | 0.32 | |||
Return On Asset | 0.0955 |
Procter Gamble DRC Leadership Team
Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathleen Fish, Chief Research, Development and Innovation Officer | ||
Craig Buchholz, Chief Communications Officer and Vice President – Communications, Personal Health Care and Oral Care | ||
Matthew Janzaruk, VP Officer | ||
Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures | ||
Debra Lee, Independent Director | ||
Mindy Sherwood, President Global Walmart | ||
Amy Chang, Independent Director | ||
Nelson Peltz, Independent Director | ||
Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations | ||
Kirti Singh, Chief Analytics and Insights Officer | ||
Francis Blake, Independent Director | ||
Thomas Finn, President - Personal Health Care | ||
Alexandra Keith, President - Global Hair Care and Beauty Sector | ||
Valarie Sheppard, Controller and Treasurer and Executive Vice President - Company Transition Leader | ||
Fama Francisco, Chief Executive Officer - Baby and Feminine Care | ||
Loic Tassel, President - Europe | ||
Margaret Whitman, Independent Director | ||
Walter McNerney, Lead Independent Director | ||
Terry Lundgren, Independent Director | ||
Shelly McNamara, Senior Vice President of Human Resources | ||
Angela Braly, Independent Director | ||
M Grabowski, Chief Human Resource Officer | ||
Javier Polit, Chief Information Officer | ||
B Allen, Independent Director | ||
Steven Bishop, Chief Executive Officer - Health Care | ||
Scott Cook, Independent Director | ||
Henry Karamanoukian, President Go-to-Market, China and Hair Care, Greater China | ||
Sundar Raman, President - Fabric Care, North America and P&G Professional, Global | ||
Susan Whaley, Chief Sec | ||
R Keith, Chief Executive Officer - Beauty | ||
Jennifer Davis, President - Feminine Care | ||
John Chevalier, Director - Investor Relations | ||
Juan Posada, President - Latin America Selling and Market Operations | ||
Fatima Francisco, Feminine Baby | ||
Monica Turner, Senior Vice President - Sales, North America | ||
Vittorio Cretella, Chief Information Officer | ||
Christine McCarthy, Independent Director | ||
Patricia Woertz, Independent Director | ||
Shailesh Jejurikar, Chief Executive Officer - Fabric and Home Care | ||
Philip Duncan, Chief Design Officer | ||
Andre Schulten, Chief Officer | ||
Marc Pritchard, Global Brand Building Officer | ||
Markus Strobel, President - Skin & Personal Care | ||
David Taylor, Chairman of the Board, President, Chief Executive Officer | ||
Joseph Jimenez, Independent Director | ||
Matthew Price, President - Greater China Selling and Market Operations | ||
Julio Nemeth, President - Global Business Services | ||
Laura Becker, President - Global Business Services | ||
Deborah Majoras, Chief Legal Officer, Secretary | ||
Jon Moeller, Vice Chairman of the Board, Chief Financial Officer | ||
Gary Coombe, President - Europe Selling and Market Operations | ||
Carolyn Tastad, Group President - North America and Chief Sales Officer | ||
Ken Patel, Chief Counsel |
Procter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.32 | |||
Return On Asset | 0.0955 | |||
Profit Margin | 0.18 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 66.88 T | |||
Shares Outstanding | 471.83 M | |||
Price To Earning | 10.71 X | |||
Price To Book | 0.65 X | |||
Price To Sales | 764.02 X | |||
Revenue | 80.19 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Procter Stock
Procter Gamble financial ratios help investors to determine whether Procter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procter with respect to the benefits of owning Procter Gamble security.